Unaudited standalone and consolidated Financial Results for the Quarter ended 30 June 2026

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 5th August 2026 Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5" Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block Dalal Street, Fort, Bandra Kurla Complex, Bandra (E) Mumbai-400 001 Mumbai-400 051 Scrip Code: BSE - 530549/ Stock Symbol: NSE – SHILPAMED Dear Sir/ Ma’am, Sub: Outcome of Board Meeting Ref: Regulation 30, 33 and 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Pursuant to Regulation 30, 33 and 42 read with Schedule III of the SEBI (LODR) Regulations, 2015, as amended it is hereby informed that the Board of Directors at their meeting held today i.e.,5th August, 2026 which commenced at 11.55 a.m. and concluded at 1.45 pm have inter alia considered and approved the following: - 1. The Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2026. A Copy of the same along with the Limited Review report is enclosed as Annexure 1. 2. Appointment of Mr. Sharath Reddy Kalakota (DIN: 03603460), Whole time Director of the Company, liable to retire by rotation, subject to member’s approval in the ensuing Annual General Meeting (AGM) - Annexure 2. 3. Payment of remuneration to Mr. Madhav Vishnukant Bhutada (DIN: 08222055) Non - Executive Director of Shilpa Biologicals Ltd (SBPL), a material subsidiary of Shilpa Medicare Limited by way of commission upto 1% net profits of SBPL w.e.f. 1 April 2026. 4. Further to our communication dated 3rd June 2026 regarding the proposed Strategic Long-Term Equity Partnership by Shilpa Biocare Private Limited ("Biocare"), a wholly owned subsidiary of Shilpa Medicare Limited, in Gate2Brain ("G2B"), we hereby inform that the proposed investment, aggregating up to EUR 7 million, is intended to be made in a fungible manner through a combination of cash infusion/equity for services/development of projects. 5. Notice of ensuing AGM: - The 39th AGM of Shilpa Medicare Limited is scheduled to be held on Friday, the 11th September 2026 at 11:00 AM through video conferencing (VC)/ other audio-visual means (OAVM) to transact the business(es) as set forth in the notice of the meeting. 6. Record date for Dividend: - Pursuant to Regulation 42 of the SEBI (LODR) Regulations, 2015, the record date for determining the shareholders entitled for payment of final dividend for FY 2025-26, if declared at the 39th AGM & Cut‐off date for determining the list of members for e-voting and participation is Friday, 4th September 2026. Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 The Company is providing remote e‐voting facility to the members in respect of resolutions to be passed at the AGM and has engaged the services of M/s KFin Technologies Limited for the said purpose. Please find the below calendar set in terms of the Companies Act, 2013 and the Rules framed thereunder read with SEBI (LODR) Regulations, 2015 for your reference: PARTICULARS OF EVENTS SCHEDULED DATES Record date Friday, 4th September 2026 Cut-off date for voting by the members and participation Friday, 4th September 2026 in AGM through VC.(The members of the record as on cut-off date would be eligible to cast their votes through remote e-voting and e-voting during the AGM) Remote e-voting will commence on Monday, 7th September 2026 at 09:00 am Remote e-Voting will end on Thursday, 10th September 2026 at 05:00 pm Date of Speaker Registration & Posting of queries Monday, 7th September 2026 at 09:00 am to Tuesday, 8th September 2026 Day, date and time of AGM Friday, 11th September 2026 at 11.00 am Website of the service provider (Kfin) for e-voting https://evoting.kfintech.com Scrutinizer for AGM: Mr. Santosh Kumar Gunemoni, partner of M/s VCAN & Associates, Practicing Company Secretaries, having membership number A60103 and COP 27836 is appointed as Scrutinizer for scrutinizing the evoting and Insta poll process under the Companies Act 2013 for the ensuing AGM to be held on 11th September 2026. The related information/ documents regarding the decision of the stock exchanges and shareholders’ approval will be informed by the Company in due course. For Shilpa Medicare Limited Ritu Tiwary Company Secretary & Compliance Officer Shilpa Medicare Limited Registered office : # 12-6-214/A -1, Hyderabad Road, Raichur -584135, Karnataka, India Website -www.vbshilpa.com, Email -info@vbshilpa.com. ,Telephone -+91-8532-238494 CIN No. -L85110KA1987PLC008739 STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 (Rs. In lakhs, except per equity share data) Quarter ended Previous year ended Particulars 30.06.2026 31.03.2026 30.06.2025 31.03.2026 (Unaudited) (Audited) (Unaudited) (Audited) 1 Income Revenue from operations 18,904 20,_111 9,346 59,703 a) Net Sales/income from operations 16,592 18,340 8,111 50,463 b) Service Income and License fees 2,312 1,771 1,235 9,240 Other Income 956 689 1,301 3,814 Total Income 19,860 20,800 10,648 63,518 2 Expenses a) Cost of material consumed 4,595 6,738 3,841 20,599 b) Purchase of stock-in-trade 637 650 384 2,211 c) Changes in inventories of finished goods, work-in-progress and Stock-in-Trade (54) 425 (1,421) (364) d) Employee benefits expense 3,417 3,001 2,576 11,099 e) Finance cost 253 262 223 1,004 f) Depreciation and amortisation expenses 1,549 1,441 1,306 5,511 g) Other expenses 4,708 3,318 1,981 10,586 Total Expenses 15,105 15,835 8,891 50,647 3 Profit before tax and exceptional items (1-2) 4,755 4,964 1,757 12,871 4 Exceptional items-lncome/(Expenses) (Pl refer note no: 03) 351 2,837 (518) 1,942 5 Profit/(Loss) before tax (3-4) 5,106 7,801 1,239 14,813 6 Tax expense (1,386) 705 (633) 1,515 (a) Current tax 1,378 567 568 2,235 (b) Current tax adjustment for earlier years {1,138) (1,138) (c) Deferred tax (Net of MAT credit)(PI refer note no: 07) (2,764) 138 442 766 (d) Deferred tax adjustment for earlier years (Net of MAT credit) 0 (505) (349) 7 Net profit/(loss) for the period/year (5-6) 6,492 7,096 1,871 13,298 8 Other com~rehensive incomeL (loss) a. Items that will not be reclassified subsequently to profit or loss 1 0 11 Remeasurement of the defined benefit (liability)/asset 1 16 Income Tax relating to the above (O) (5) b. Items that will be reclassified subsequently to profit or loss Total other comprehensive income/(loss) (net of tax)(a+b) (1) (0) (11) 9 Total comprehensive income for the period/ year (7+8) 6,492 7,095 1,871 13,287 10 Paid up equity share capital (par Value Rs.1/-each, fully paid) 1,956 1,956 978 1,956 11 Reserves i.e Other equity 269,382 12 Earnings per equity share (par value Rs.1/-each) (Pl refer note no: 6) (Not annualised) (Not annualised) (Not annualised) (Annualised) Basic (Rs.) 3.32 3.63 0.96 6.80 Diluted (Rs.) 3.32 3.63 0.96 6.80 For and on behalf of the Board of Directors Date: 05.08.2026 Place: Raichur Shilpa Medicare Limited ......_~ 1· lonov.lbng frx Registered office : # 12-6-214/A -1, Hyderabad Road, Raichur -584135, Karnataka, India ~ affc:w-dable heal Website -www.vbshilpa.com, Email -info@vbshilpa.com. ,Telephone -+91-8532-238494 CIN No. -L85110KA1987PLC008739 STATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 (Rs. In lakhs, except per equity share data) Quarter ended Previous year ended Particulars 30.06.2026 31.03.2026 30.06.2025 31.03.2026 (Unaudited) (Audited) (Unaudited) (Audited) 1 Income Revenue from operations, 46,578 43,699 32,147 153,887 a) Net Sales/income from operations 39,001 37,346 26,444 127,254 b) Service Income and License fees 7,577 [Showing first 8,000 characters — download PDF for full document]